Galbraith, Sally, Cameron, Barbara, Li, Hui et al. · The Journal of infectious diseases · 2011 · DOI
Researchers studied blood samples from 18 people who developed long-lasting fatigue after three different infections (Epstein-Barr virus, Ross River virus, and Q fever) and compared them to 18 healthy people who recovered normally. They looked for patterns in which genes were turned on or off that might explain the fatigue syndrome. While they found some differences in gene activity, these patterns were not consistent across the different infection groups, suggesting there may not be a single blood-based marker that identifies post-infectious fatigue.
This study is important because it directly addresses whether blood-based gene expression signatures can identify or explain ME/CFS, a key question for developing diagnostic tests and understanding disease mechanisms. The inclusion of multiple infection triggers and longitudinal sampling provides valuable evidence about whether postinfective fatigue syndromes share a common biological signature, which has implications for treatment strategies.
This study does not prove that ME/CFS has no biological basis—it only shows that a single, consistent gene expression signature in peripheral blood may not exist across different triggering infections. The absence of a universal biomarker does not rule out abnormalities in other tissues, immune cell subtypes, or alternative biological mechanisms. Lack of consistent findings across cohorts may reflect genuine biological differences between infection-triggered syndromes rather than absence of pathology.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →